Federica F. O’brien

Biography

Ms. O’Brien brings 30 years of financial and operational leadership for both public and private companies to Complexa. Ms. O’Brien has held a management role at multiple life science companies including Barrier Therapeutics, Cardiokine, Inc, Cervilenz Inc, and Cerecor Inc. Ms. O’Brien has been key to raising capital and readying companies for the public markets. Most recently at Cerecor, Ms. O’Brien was instrumental in a $32 million Series B financing. While at Cervilenz, in addition to raising capital, Ms. O’Brien led the expansion of the patent portfolio worldwide and was influential in obtaining CE marking and ISO 13485 certification for a women’s healthcare device. Previously, Ms. O’Brien was Chief Financial Officer of privately-held Cardiokine Inc., a biotechnology company developing compounds for the treatment and prevention of cardiovascular disease. She helped raise $87 million of venture funding and played a central role in establishing a collaboration agreement which provided Cardiokine with significant funding for development. During 2004, Ms. O’Brien was integral to the IPO at Barrier Therapeutics, where she served as Controller. Earlier in her career, she was Chief Financial Officer of Infonautics, Inc, a publicly held technology based company, and began her career in public accounting, most recently at Coopers & Lybrand (PWC).

Research Interest

Business Administration